Measurement of plasma glucagon in humans - a shift in the performance of a current commercially available RIA kit.

dc.contributor.authorWu, T.
dc.contributor.authorRayner, C.K.
dc.contributor.authorJones, K.L.
dc.contributor.authorHorowitz, M.
dc.contributor.authorFeinle-Bisset, C.
dc.contributor.authorStandfield, S.D.
dc.contributor.authorXie, C.
dc.contributor.authorDeacon, C.F.
dc.contributor.authorHolst, J.J.
dc.contributor.authorWewer Albrechtsen, N.J.
dc.date.issued2022
dc.descriptionLetter to Editor
dc.description.abstractAbstract unavailable.
dc.description.statementofresponsibilityTongzhi Wu, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Christine Feinle-Bisset, Scott D. Standfield, Cong Xie, Carolyn F. Deacon, Jens J. Holst, Nicolai J. Wewer Albrechtsen
dc.identifier.citationDiabetes, Obesity and Metabolism, 2022; 24(6):1182-1184
dc.identifier.doi10.1111/dom.14673
dc.identifier.issn1462-8902
dc.identifier.issn1463-1326
dc.identifier.orcidWu, T. [0000-0003-1656-9210]
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]
dc.identifier.orcidFeinle-Bisset, C. [0000-0001-6848-0125]
dc.identifier.orcidXie, C. [0000-0002-0054-9269]
dc.identifier.urihttps://hdl.handle.net/2440/145903
dc.language.isoen
dc.publisherWiley
dc.rights© 2022 John Wiley & Sons Ltd
dc.source.urihttps://doi.org/10.1111/dom.14673
dc.subjectLetter to editor; clinical trials; ELISA; glucagon; RIA
dc.subject.meshPlasma
dc.subject.meshHumans
dc.subject.meshGlucagon
dc.subject.meshRadioimmunoassay
dc.titleMeasurement of plasma glucagon in humans - a shift in the performance of a current commercially available RIA kit.
dc.typeJournal article
pubs.publication-statusPublished online

Files

Collections